Risk Information “Window” Proposed By FDA For DTC Print Ads

A "risk information window" with bullet points is being proposed by FDA as an alternative to presentation of adverse events and warnings in the text of prescription drug direct-to-consumer ads

Pink Sheet Podcast

Learn what's happening at the US FDA. On the go.

Derrick Gingery and the team bring you a weekly "Drug Fix".

More from Archive

More from Pink Sheet